The Hospice Gold Rush: Why Private Equity Wants to Buy Your Last Days

Wall Street has discovered that dying is a highly predictable, incredibly lucrative business model—and your family is the target.

In 2018, a private equity firm bought a midsize hospice provider in the Southeast for $120 million, stripped down its nursing staff, and sold it three years later for $205 million. This is not an isolated corporate success story; it is the standard playbook for the modern American way of dying. Over the last decade, private equity firms have quietly acquired hundreds of hospice providers across the country, transforming a service designed for comfort into a high-margin volume game.

More from Inside the Industry →   ·   Back to Perch   ·   Browse all stories